Skip to main content
AstraZeneca PLC
Healthcare · Drug Manufacturers - General
Made on Aug 2, 2026
Price at call $169.64
6-month call Bear -7.2%
Target by Feb 2027 $157.50
Great value below $145.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -7.2% to $157.50
Predicted High $169.90 in 2 weeks
Predicted Low $157.50 at 6 months
Max Drawdown (predicted) -7.2%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 2, 2026 12:41 am
Bear AZN trends lower to $157.50 (-7.2% from $169.64) by Feb 2027. decay
ThesisAZN trades meaningfully above composite fair value ($132) with a negative value net and weak recent momentum, but a defensive low-beta profile, mild sentiment tailwind from EU oncology approval, and no near-term earnings catalyst suggest gradual value gravity rather than a sharp de-rate. Expect a slow drift lower toward the DCF/anchored-PE band over 6 months.
Invalidated ifA break above $178 on positive pipeline news, or a break below $150 signaling faster mean-reversion to fair value
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $169.64 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 2, 2026 $169.64 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 16, 2026 $159.16–$180.12 typical range · internal point $169.90 ±6.2% 6/10 Low-beta drift in neutral tape, no catalyst
What actually happened: closed $156.45 on Aug 14, 2026 = -7.8% vs the call (predicted +0.2%)  ·  direction MISS (called flat, was down)  ·  off by 7.9 pp  ·  accuracy 4/10  ·  typical range ±6.2%: OUTSIDE the band  ·  S&P +4.7% over the same window — beat it
1 month Sep 2, 2026 $154.46–$184.82 typical range · internal point $168.50 ±8.9% 5/10 Sentiment tailwind fades, mild value gravity begins
2 months Oct 2, 2026 $165.80 -2.3% 5/10 Overvaluation pressure builds without new catalyst
3 months Nov 2, 2026 $163.00 -3.9% 4/10 Slow convergence toward DCF anchor near 154
4 months Dec 2, 2026 $161.50 -4.8% 4/10 Defensive bid cushions decline into year-end
5 months Jan 2, 2027 $159.00 -6.3% 4/10 Post-holiday repositioning, value lens still negative
6 months Feb 2, 2027 $157.50 -7.2% 3/10 Approaches anchored-PE band as fair value asserts

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $167.67 (-1.2%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$169.64
Composite fair value$132.40
Signal-adjusted fair value$136.62
DCF fair value$154.03
Anchored-PE fair value$148.32
Buy-below (value lens)$145.00
Value net score-69
Value confidence7 / 10
Quality net score+55
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 40.0%  3m 31.0%  6m 28.7%  
Daily σ (realism noise)2.0%
Beta vs S&P 500 1m -0.55  3m -0.14  5m 0.23  
Trailing 6-month return-8.4%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 2, 2026 freshest AZN-20260802-000311-0a62
ext-forensic-memo Aug 2, 2026 freshest ext-AZN-20260802-002813-f59f
ext-lens-quality Aug 2, 2026 freshest ext-AZN-20260802-002813-f59f
ext-lens-sentiment Aug 2, 2026 freshest ext-AZN-20260802-002813-f59f
ext-lens-value Aug 2, 2026 freshest ext-AZN-20260802-002813-f59f
scenario-valuation Aug 2, 2026 freshest AZN-20260802-000311-0a62
valuation-synthesis Aug 2, 2026 freshest AZN-20260802-000311-0a62

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 2, 2026 v0.6.0 Bear $169.64 $157.50 -7.2% Feb 2027 viewing
Jun 25, 2026 v0.3.0 Neutral $183.02 $180.41 -1.4% Dec 2026 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.